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The infectiousness of  the index case and the susceptibil- 
ity of the exposed host  mediate the sexual transmission 
of human immunodefic iency virus (HIV). Infectiousness of
the index case is determined by the inoculum of HIV and 
viral factors that favor transmission. 1 Persons with pri- 
mary  infection, late stage disease, or  low CD4 counts 
appear to transmit HIV with greater efficiency, presum- 
ably through increased viral burden in genital secretions. 1-6 
Susceptibility o HIV infection is determined by hereditary 
resistance factors, acquired immunity, site of exposure to 
the virus, and integrity of local barriers (e.g., vaginal epithe- 
lium). 7 Hereditary resistance factors, such as cell surface 
receptors required for transmission of  some viral variants, 
have been fdentified in studies of exposed, but  uninfected 
persons, s Acquired immunity, including protect ive cyto- 
toxic T lymphocyte or antibody responses, may be impor- 
tant in persons repeatedly exposed to HIV who do not 
become infected? Sexual practices also affect suscepti- 
bility, with receptive anal intercourse having the highest 
risk, fol lowed by vaginal intercourse and fellatio. 2 Simi- 
larly, women are more susceptible to infection than men, 
through vaginal intercourse. TM In general, any factor affect- 
ing excretion of HIV or the number of receptive cells can 
be expected to affect the efficiency of transmission. 1°,1~ 
Classic sexually transmitted diseases (STD) that cause 
ulceration or mucosal  inf lammation appear  to be pow- 
erful  co factors  for t ransmiss ion  of  HIV, 12,13 and may 
increase infectiousness, susceptibility, or both. The poten- 
tial for increased infectiousness has been shown in recent 
studies document ing  increased concentrat ions of HIV in 
secretions of men and women with coexist ing STDs. 14-19 
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Inf lammation associated wi th  an STD could also lead to 
excret ion of  more infectious HIV variants. Sexually trans- 
mitted diseases also are bel ieved to increase susceptibi l-  
ity to H1V infection. Genital ulcers are assumed to disrupt 
the mucosal  barrier, thereby increasing susceptibil ity. 13 
Endocervical inflammation is associated with recruitment 
of cells recept ive to HI~. 2° 
Despite the large number  of studies demonstrat ing a 
relation between STDs and HIV infection, some uncer- 
tainty regarding a causal role for STDs remains. Many stud- 
ies examining HIV and STDs have been cross-sect ional- -  
determining HIV and STD status simultaneously. 21-26 Inter- 
pretation of these studies is problematic,  because the tim- 
ing of the relation between the STD and the acquisit ion 
of HIV is not  known. Concurrent  ulcerative STDs and 
HIV infection may simply represent  increased suscepti- 
bility to the STD in an immunocompromised HIV-infected 
host. Prevalent STDs among HW-infected persons,  par- 
Ocularly mucosal STDs, such as gonorrhea, chlamydia, and 
tr ichomoniasis,  are unlikely to be related to the acquisi- 
t ion of HIV infection, unless the observed HIV infection 
is acute. In many studies, in f lammatory  and ulcerat ive 
STDs most  clearly represent sexual risk-taking behavior  
consistent with acquisit ion of  HIM 
Cohort  or longitudinal studies are necessary to exam- 
ine directly the relation between STDs and HIV infection 
more precisely. Genital u lcer disease has been associated 
wi th  increased inc idence of  HIV infection in men and 
women.  27-29 Urethritis in men and cervicit is in women 
have been associated with increased risk for acquir ing 
HIV infection. 29 Gonorrhea, chlamydial  infection, or  tri- 
chomoniasis  have been i 'eported to increase the risk for 
HIV infection in women.  3° However, these studies are dif- 
ficult to perform. Demonstrat ion of a possible causal ink- 
age fo r ' suscept ib i l i ty  requ i res  demonst ra t ion  of  the  
presence of  an STD fol lowed in short  temporal  sequence 
by HIV seroconversion. With many STDs, the risk per iod  
for HIV acquisit ion is short, because symptoms will lead 
infected persons to seek treatment.  Furthermore, it is dif- 
f icult  to d i scern  whether  an STD is assoc iated w i th  
increased infectiousness and is cotmnsmitted by the index 
case, or  if the STD is prevalent in the secondary case and 
increases usceptibil ity. 
Studies using couples discordant for HIV infection 
represent  a novel way to study the relation of HIV infec- 
tion and STDs. Several studies of  discordant couples have 
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been published that allow the assessment of particular 
risk factors that influence HIV transmission, because inci- 
dent infections in the seronegative partner are likely to 
be transmitted from the seropositive partner. 31-43 Resis- 
tance factors also can be assessed in these studies. Many 
of these studies have shown a relation between immuno- 
suppress ion or advanced isease and HIV transmis- 
sion. 31-37 An increased  viral burden  also has been 
associated with increased risk of transmission. 39,4°,43 One 
study identified receptive anal intercourse by women as 
a risk factor for increased susceptibil ity for HIV infec- 
tion. 38 In this same study, STDs, especially ulcerative STDs, 
were associated with an increased risk that did not attain 
statistical significance. 3s 
In this issue of the International Journal of Infec- 
tious Diseases, Perez and coworkers report on the effects 
of STDs on transmission of HIV in a large study of dis- 
cordant couples. 44 In an effort to examine factors pro- 
mot ing transmiss ion,  a cohor t  of 224 heterosexual  
couples in stable partnerships was recruited from 1990 
tO 1995. 45,46 However, transmission proved to be a rare 
event. Since the couples were aggressively counseled 
about HIV prevention, prevention of transmission i the 
cohort can be considered a great success, albeit at the 
cost of the initial study design. 
In an alternative design, the investigators recruited 78 
concordant couples (both partners HIV infected) for com- 
parison. 44-46 In earlier work, these researchers eported on 
demographic, behavioral, and biologic factors that appear 
to separate concordant and discordant couples. 45,46 In these 
earlier studies, no differences in history of STDs were noted 
in concordant and discordant couples, but women in con- 
cordant couples were more likely to have inflammation 
or cervical dysplasia detected by Pap smear. 4s 
The current analysis was undertaken to determine 
whether several different STDs might influence HIV trans- 
mission. Prior infections by herpes simplex virus type 2 
(HSV-2), cytomegalovirus, syphilis, hepatitis B, Chlamy- 
alia trachomatis, and Mycoplasma species, including M. 
genitalium, M. fermentans, and M. penetrans, were deter- 
mined by serum antibody status. The most important 
result was that seroprevalences of HSV-2 and 34. genital- 
ium were much higher in concordant couples than in dis- 
cordant couples. Among couples with ar male index case, 
the odds of HIV concordancy were approximately three 
times greater if both partners were seropositive for HSV-2 
and two times greater for M. genitalium. No significant 
relation was observed for hepatitis B, cytomegalovirus, 
or syphilis. No increase in the prevalence of gonorrhea, 
chiamydia, or trichomoniasis (detected by culture or anti- 
gen detection) was detected in the concordant couples. 
As noted by the authors, the cross-sectional study 
design limits interpretation f these results. The failure to 
observe a relation between the mucosal STDs, gonorrhea, 
chlamydia, nd trichomoniasis,  likely due to evaluation 
of prevalent infections. The observed relation between 
HSV-2 and HIV infection, as well as M. genitaHum and 
H1V infection, may be explained in several ways. The most 
intriguing possibility is that these infections facilitated 
HIV transmission, by increasing either infectiousness or
susceptibility, or both. Unfortunately, there is no way of 
knowing which infections came first. Thus, an alterna- 
tive explanation is that couples with HIV infection could 
"share" STDs more  readi ly,  espec ia l l y  recogn iz ing  
increased shedding of HSV-2 in genital secretions of 
patients with HIV. 47 Furthermore, the multivariable analy- 
sis was apparently limited to stage of H1V disease and 
infection status; although vaginal and anal intercourse did 
not account for the fmdings, the possibility remains that 
other factors could explain the observations. 
Further elucidation of the relation between HIV infec- 
tion and STDs, including HSV-2,M. genitalium, and other 
mucosal infections, is essential. If the hypotheses pro- 
posed by Perez are substantiated, these common infec- 
t ions may account  for a s ign i f icant  p ropor t ion  of  
heterosexual HIV transmission. From a population per- 
spective, the importance of a risk factor is a function of 
both the relative risk of the factor and its prevalence in 
the populat ion.  Although syphil is and chancroid are 
believed to have high relative risks for HIV transmission, 
they are relatively uncommon infections in the United 
States. In contrast, he relatively common mucosal STDs, 
such as chlamydia, trichomoniasis, and gonorrhea, may 
play a major role in the sexual transmission of HIV infec- 
tion because of their high prevalence. The data of Perez 
et al suggest hat herpes simplex and Mycoplasma lso 
should be added to the suspect list. 44 Herpes simplex 
virus-2 is a common infection, with an estimated preva- 
lence of 22% in the United States. 48 The recognition that 
viral shedding occurs without an overt ulcer may also 
have impor tant  ramif icat ions for HIV transmission.  
Mycoplasma genitalium, also a common infection, is 
found in both symptomatic and asymptomatic persons. 49 
Given the accumulated evidence for the relation 
between HIV and STDs, both behavioral and biologic 
strategies to preYent HIV transmission are warranted. In 
the absence of a vaccine, it is critical to reduce HIV infec- 
tiousness and susceptibility. Treatment of uret'hritis and 
cervicit is reduces excret ion of HIV in the urethra,X6 
semen, ~4 and vaginal secretions. 17-19 Syndromic treatment 
of acute ulcerative and-intqammatoiT S Ds reduces the 
incidence of HW. 5° 
The work from Perez and co-workers uggests that 
treatment of HSV-2 and M. genitalium might also pre- 
vent HIV transmission. 44 Current therapeutic strategies 
for these infections would be insufficient for this pur- 
pose. Therapy for HSV-2 is used to suppress ymptomatic 
vesicles or ulcers, but has not been used to reduce asymp- 
tomatic viral shedding, although this idea has recently 
gained considerable attention. 51For Mycoplasma infec- 
tions single-dose therapy is available, s2However, asymp- 
tomatic infections are neither diagnosed nor treated. 
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Recommendat ions  to alter approaches  to STD man- 
agement  to p revent  HIV in fect ion  cannot  be  made on 
the basis o f  the  observat ions  by  Perez et al. ~4 However ,  
these resul ts  raise a number  o f  in t r igu ing poss ib i l i t ies  
that must  be  conf i rmed wi th  more  r igorous study designs. 
If con f i rmed,  these results wi l l  have substantial  implica- 
t ions for publ ic  health in the Uni ted States and e lsewhere.  
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